255 related articles for article (PubMed ID: 22974689)
1. Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model.
Perche F; Patel NR; Torchilin VP
J Control Release; 2012 Nov; 164(1):95-102. PubMed ID: 22974689
[TBL] [Abstract][Full Text] [Related]
2. The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors.
Sarisozen C; Abouzeid AH; Torchilin VP
Eur J Pharm Biopharm; 2014 Oct; 88(2):539-50. PubMed ID: 25016976
[TBL] [Abstract][Full Text] [Related]
3. Stability influences the biodistribution, toxicity, and anti-tumor activity of doxorubicin encapsulated in PEG-PE micelles in mice.
Wei X; Wang Y; Zeng W; Huang F; Qin L; Zhang C; Liang W
Pharm Res; 2012 Jul; 29(7):1977-89. PubMed ID: 22426964
[TBL] [Abstract][Full Text] [Related]
4. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells.
Wang J; Qu H; Jin L; Zeng W; Qin L; Zhang F; Wei X; Lu W; Zhang C; Liang W
J Pharm Sci; 2011 Jun; 100(6):2267-77. PubMed ID: 21246559
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin-mediated radiosensitivity in multicellular spheroids from a lung cancer cell line is enhanced by composite micelle encapsulation.
Xu WH; Han M; Dong Q; Fu ZX; Diao YY; Liu H; Xu J; Jiang HL; Zhang SZ; Zheng S; Gao JQ; Wei QC
Int J Nanomedicine; 2012; 7():2661-71. PubMed ID: 22679376
[TBL] [Abstract][Full Text] [Related]
6. PEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma.
Xiao K; Luo J; Li Y; Lee JS; Fung G; Lam KS
J Control Release; 2011 Oct; 155(2):272-81. PubMed ID: 21787818
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy of experimental B-16 melanoma in mice with tumor-targeted 5,10,15,20-tetraphenylporphin-loaded PEG-PE micelles.
Skidan I; Dholakia P; Torchilin V
J Drug Target; 2008 Jul; 16(6):486-93. PubMed ID: 18604661
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity.
Koren E; Apte A; Jani A; Torchilin VP
J Control Release; 2012 Jun; 160(2):264-73. PubMed ID: 22182771
[TBL] [Abstract][Full Text] [Related]
9. In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer.
Kim D; Gao ZG; Lee ES; Bae YH
Mol Pharm; 2009; 6(5):1353-62. PubMed ID: 19507896
[TBL] [Abstract][Full Text] [Related]
10. Mixed PEG-PE/vitamin E tumor-targeted immunomicelles as carriers for poorly soluble anti-cancer drugs: improved drug solubilization and enhanced in vitro cytotoxicity.
Sawant RR; Sawant RM; Torchilin VP
Eur J Pharm Biopharm; 2008 Sep; 70(1):51-7. PubMed ID: 18583114
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin loaded pH-sensitive micelle: antitumoral efficacy against ovarian A2780/DOXR tumor.
Kim D; Lee ES; Park K; Kwon IC; Bae YH
Pharm Res; 2008 Sep; 25(9):2074-82. PubMed ID: 18449626
[TBL] [Abstract][Full Text] [Related]
12. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.
Xu Y; Lu Y; Wang L; Lu W; Huang J; Muir B; Yu J
Colloids Surf B Biointerfaces; 2016 May; 141():318-326. PubMed ID: 26874117
[TBL] [Abstract][Full Text] [Related]
13. Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin.
Tang N; Du G; Wang N; Liu C; Hang H; Liang W
J Natl Cancer Inst; 2007 Jul; 99(13):1004-15. PubMed ID: 17596572
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin-loaded PEG-PCL copolymer micelles enhance cytotoxicity and intracellular accumulation of doxorubicin in adriamycin-resistant tumor cells.
Diao YY; Li HY; Fu YH; Han M; Hu YL; Jiang HL; Tsutsumi Y; Wei QC; Chen DW; Gao JQ
Int J Nanomedicine; 2011; 6():1955-62. PubMed ID: 21976972
[TBL] [Abstract][Full Text] [Related]
15. PEG-PE/phosphatidylcholine mixed immunomicelles specifically deliver encapsulated taxol to tumor cells of different origin and promote their efficient killing.
Gao Z; Lukyanov AN; Chakilam AR; Torchilin VP
J Drug Target; 2003 Feb; 11(2):87-92. PubMed ID: 12881194
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin in TAT peptide-modified multifunctional immunoliposomes demonstrates increased activity against both drug-sensitive and drug-resistant ovarian cancer models.
Apte A; Koren E; Koshkaryev A; Torchilin VP
Cancer Biol Ther; 2014 Jan; 15(1):69-80. PubMed ID: 24145298
[TBL] [Abstract][Full Text] [Related]
17. Enhanced targeting of 3D pancreatic cancer spheroids by aptamer-conjugated polymeric micelles with deep tumor penetration.
Tian L; Pei R; Zhong L; Ji Y; Zhou D; Zhou S
Eur J Pharmacol; 2021 Mar; 894():173814. PubMed ID: 33352182
[TBL] [Abstract][Full Text] [Related]
18. Enhanced in vivo antitumor efficacy of poorly soluble PDT agent, meso-tetraphenylporphine, in PEG-PE-based tumor-targeted immunomicelles.
Roby A; Erdogan S; Torchilin VP
Cancer Biol Ther; 2007 Jul; 6(7):1136-42. PubMed ID: 17611407
[TBL] [Abstract][Full Text] [Related]
19. Nanomedicine based curcumin and doxorubicin combination treatment of glioblastoma with scFv-targeted micelles: In vitro evaluation on 2D and 3D tumor models.
Sarisozen C; Dhokai S; Tsikudo EG; Luther E; Rachman IM; Torchilin VP
Eur J Pharm Biopharm; 2016 Nov; 108():54-67. PubMed ID: 27569031
[TBL] [Abstract][Full Text] [Related]
20. Block copolymer micelles with acid-labile ortho ester side-chains: Synthesis, characterization, and enhanced drug delivery to human glioma cells.
Tang R; Ji W; Panus D; Palumbo RN; Wang C
J Control Release; 2011 Apr; 151(1):18-27. PubMed ID: 21194551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
